Sunshine Biopharma, Inc. ( SBFMW) - Stock Earnings
SBFMW Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026, midnight | — / — | — | — / — | — |
SBFMW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -883820 USD | 9.4 million USD |
| 2025Q4 | -2.1 million USD | 8.6 million USD |
| 2026Q1 | -1.2 million USD | 8.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SBFMW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -4.5 million USD | 24.1 million USD |
| 2024 | -5.1 million USD | 34.9 million USD |
| 2025 | -6.0 million USD | 36.3 million USD |
| 2026 Est. | — | — |
SBFMW
Price: $0.03
52 week price:
Earnings Per Share: -2.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 210244